Volume 97, Issue 6 pp. 1290-1295
ORIGINAL STUDIES

Clinical outcomes of percutaneous debulking of tricuspid valve endocarditis in intravenous drug users

Yasir N. Akhtar MBBS

Corresponding Author

Yasir N. Akhtar MBBS

Tennova Healthcare, Turkey Creek Medical Center, Knoxville, Tennessee, US

Correspondence

Yasir N. Akhtar MBBS, 7565 Dannaher Drive, Suite 201, North Knoxville Medical Center, Knoxville, TN 37849.

Email: [email protected]

Search for more papers by this author
William A. Walker MD

William A. Walker MD

Tennova Healthcare, Turkey Creek Medical Center, Knoxville, Tennessee, US

Search for more papers by this author
Umar Shakur DO

Umar Shakur DO

Sturdy Memorial Hospital, Attleboro, Massachusetts, US

Search for more papers by this author
Gary Smith RCDS

Gary Smith RCDS

Tennova Healthcare, Turkey Creek Medical Center, Knoxville, Tennessee, US

Search for more papers by this author
Syed S. Husnain MD

Syed S. Husnain MD

Tennova Healthcare, Turkey Creek Medical Center, Knoxville, Tennessee, US

Search for more papers by this author
Shade F. Adigun PhD, FNP-BC

Shade F. Adigun PhD, FNP-BC

Tennova Healthcare, Turkey Creek Medical Center, Knoxville, Tennessee, US

Search for more papers by this author
First published: 01 March 2021
Citations: 16

Abstract

Objectives

A retrospective case series of a percutaneous approach to debulk tricuspid valve endocarditis (TVE) using an 8 French mechanical aspiration system in patients with a history of intravenous drug use (IVDU) was reported. IVDU associated TVE is increasing in the United States and is associated with high mortality despite early surgical debridement. Patients with advanced disease, shock, and respiratory failure may not be candidates for surgical debridement or replacement. These patients have recurrent events despite medical therapy

Methods

About 25 patients with IVDU associated TVE with persistent bacteremia confirmed by repeat blood cultures after 72 hr of sensitivity directed antibiotics and presence of pulmonary emboli confirmed by computed tomographic (CT) scan, who had undergone percutaneous aspiration were included. Patients were all deemed high risk for surgical debridement by a CT surgeon and evaluated by an infectious disease consultant. Procedures were performed under moderate sedation with intracardiac echo and a steerable guide with a CAT8 Penumbra aspiration catheter.

Results

There were no intraprocedural deaths or complications. About 36% had septic shock on presentation. Survival of index hospitalization was 88%. Repeat blood cultures showed no growth on all surviving patients. Readmission rate was 4% (n = 1) at 1 month. About 40% (n = 2) patients with septic shock survived at 1 month compared with 100% survival (n = 20) in those without shock. Presence of septic shock was associated with reduced survival at 1 month (p < .01).

Conclusion

Percutaneous mechanical aspiration with an 8 Fr system is a feasible, minimally invasive alternative to surgical debulking. Mortality remains high in those presenting with septic shock. Further studies are needed to evaluate long-term outcomes.

CONFLICTS OF INTEREST

The authors declare no conflicts of interest.

DATA AVAILABILITY STATEMENT

The data that support the findings of this study are available from the corresponding author upon reasonable request.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.